Lishui, 323000
China
SARS-CoV-2; COVID-19; Pneumonia; Computed tomography
angiogenesis; hepatocellular carcinoma (HCC); diagnosis; recurrence; prognosis; piperlongumine
ferroptosis; hepatocellular carcinoma (HCC); TMB; immune microenvironment; prognosis
apoptosis; hepatocellular carcinoma (HCC); overall survival (OS); relapse-free survival (RFS); prognosis